Bernardini G, Hedrick J, Sozzani S, Luini W, Spinetti G, Weiss M, Menon S, Zlotnik A, Mantovani A, Santoni A, Napolitano M
Regina Elena Cancer Institute, Department of Experimental Medicine and Pathology, University of Rome, La Sapienza, Italy.
Eur J Immunol. 1998 Feb;28(2):582-8. doi: 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO;2-A.
Chemokines are key molecules in directing leukocyte migration toward sites of inflammation. We have previously cloned a putative CC chemokine receptor gene, TER1, whose expression is restricted to lymphoid tissues and cell lines. Recently, this receptor has been shown to signal in response to the human CC chemokine I-309 and thus it has been renamed CCR8 according to the current nomenclature. In the present study, we report the identification of the CC chemokines thymus and activation-regulated cytokine (TARC) and macrophage inflammatory protein-1 beta (MIP-1 beta) as CCR8 ligands, as they induce chemotaxis in CCR8 Jurkat stable transfectants. Furthermore, we have generated a polyclonal antiserum that is able to recognize the CCR8 molecule in transfectant lysates. The pattern of CCR8 mRNA expression and the functional effects exerted by its ligand suggest that the triggering of this receptor may regulate multiple functions including activation, migration and proliferation of lymphoid cells.
趋化因子是引导白细胞向炎症部位迁移的关键分子。我们先前克隆了一个假定的CC趋化因子受体基因TER1,其表达仅限于淋巴组织和细胞系。最近,该受体已被证明可对人CC趋化因子I-309产生信号应答,因此根据当前命名法将其重新命名为CCR8。在本研究中,我们报告了CC趋化因子胸腺和活化调节细胞因子(TARC)以及巨噬细胞炎性蛋白-1β(MIP-1β)作为CCR8配体的鉴定结果,因为它们可在CCR8 Jurkat稳定转染子中诱导趋化作用。此外,我们制备了一种能够识别转染子裂解物中CCR8分子的多克隆抗血清。CCR8 mRNA的表达模式及其配体发挥的功能效应表明,该受体的激活可能调节多种功能,包括淋巴细胞的活化、迁移和增殖。